BOPA Digital Subcommittee – new members required

The BOPA digital subcommittee are looking for new members. The primary purpose of the BOPA digital subcommittee is to promote excellence in the pharmaceutical care of patients by supporting membership through digital support and increased communication streams. The group has 4 pillars – membership, website, social media and education and technology. More details on the role of the group can be found here

We are looking for members who have a passion for getting information to people in different ways.
You don’t need to be an expert of computers or building websites, or a social media influencer, all necessary training and support will be provided; all you need is to be willing to get involved and be part of the digital team.

If you are interested or would like to know more, please contact [email protected] for further information.

Clayton Wong & Kelly Baillie

BOPA Digital Subcommittee Co-Chairs

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article